Gillies Hunter

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
15
Insider Sells Sum
$1.52M

Insider Activity of Gillies Hunter

According to the SEC Form 4 filings, Gillies Hunter, being in a position of

  1. CHIEF MEDICAL OFFICER at Aerovate Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 47100 shares for $1.15M,
    over all time since 2023-04-21, has bought 0 shares, and sold 66152 shares for $1.52M.

The largest sale of all time was on 2024-03-28 and amounted to 9000 shares of Aerovate Therapeutics, Inc. for $265,500.

Biography of Gillies Hunter

No biography is available at this moment.

2024-06-13SaleAerovate Therapeutics, Inc.
AVTE
CHIEF MEDICAL OFFICER
6,000
0.0229%
$24.50$147,000-91.7%
2024-05-17SaleAerovate Therapeutics, Inc.
AVTE
CHIEF MEDICAL OFFICER
4,000
0.0136%
$21.08$84,332-89.72%
2024-04-17SaleAerovate Therapeutics, Inc.
AVTE
CHIEF MEDICAL OFFICER
4,000
0.0143%
$22.38$89,522-88.67%
2024-03-28SaleAerovate Therapeutics, Inc.
AVTE
CHIEF MEDICAL OFFICER
9,000
0.0322%
$29.50$265,500-91.37%
2024-03-18SaleAerovate Therapeutics, Inc.
AVTE
CHIEF MEDICAL OFFICER
7,000
0.0248%
$25.87$181,057-90.03%
2024-03-07SaleAerovate Therapeutics, Inc.
AVTE
CHIEF MEDICAL OFFICER
8,975
0.0326%
$24.50$219,888-89.21%
2024-02-23SaleAerovate Therapeutics, Inc.
AVTE
CHIEF MEDICAL OFFICER
511
0.0019%
$19.50$9,965-86.45%
2024-02-20SaleAerovate Therapeutics, Inc.
AVTE
CHIEF MEDICAL OFFICER
3,489
0.0137%
$20.23$70,575-85.77%
2024-01-17SaleAerovate Therapeutics, Inc.
AVTE
CHIEF MEDICAL OFFICER
4,000
0.014%
$19.50$78,000-14.93%
2023-12-27SaleAerovate Therapeutics, Inc.
AVTE
CHIEF MEDICAL OFFICER
125
0.0005%
$24.50$3,063-25.54%
2023-12-20SaleAerovate Therapeutics, Inc.
AVTE
CHIEF MEDICAL OFFICER
4,000
0.0148%
$19.50$78,000-4.82%
2023-12-14SaleAerovate Therapeutics, Inc.
AVTE
CHIEF MEDICAL OFFICER
9,897
0.0362%
$19.50$192,992-2.57%
2023-05-19SaleAerovate Therapeutics, Inc.
AVTE
CHIEF MEDICAL OFFICER
65
0.0003%
$19.50$1,268-7.55%
2023-05-17SaleAerovate Therapeutics, Inc.
AVTE
CHIEF MEDICAL OFFICER
1,090
0.0044%
$19.59$21,356-11.87%
2023-04-21SaleAerovate Therapeutics, Inc.
AVTE
CHIEF MEDICAL OFFICER
4,000
0.0163%
$19.50$78,000-12.15%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.